Sabby Management, LLC Closed Holding Positions

Sabby Management, LLC

  • $9.65 Million
  • Q4 2024
Stock Closed Quarter Shares Sold Price Range Trade History
XENE
Xenon Pharmaceuticals Inc.

Healthcare
Q2 2018 Filed on Aug 14, 2018
67,000
$4.8 - $9.2 $322K - $616K
MRK
Merck & Co., Inc.

Healthcare
Q2 2018 Filed on Aug 14, 2018
6,864
$50.83 - $59.72 $349K - $410K
Ptc Therapeutics Inc
Q2 2018 Filed on Aug 14, 2018
1,475
N/A
Inspiremd Inc
Q2 2018 Filed on Aug 14, 2018
243,794
N/A
Prothena Corporation PLC
Q2 2018 Filed on Aug 14, 2018
240
N/A
Merck & CO Inc
Q2 2018 Filed on Aug 14, 2018
2,490
N/A
ALNY
Alnylam Pharmaceuticals, Inc.

Healthcare
Q2 2018 Filed on Aug 14, 2018
11,500
$88.31 - $107.8 $1.02M - $1.24M
Incyte Corp
Q2 2018 Filed on Aug 14, 2018
1,140
N/A
Bio Path Holdings Inc
Q2 2018 Filed on Aug 14, 2018
85,013
N/A
Versartis Inc
Q2 2018 Filed on Aug 14, 2018
200
N/A
Vertex Pharmaceuticals Inc
Q2 2018 Filed on Aug 14, 2018
1,315
N/A
GLYC
Glycomimetics Inc

Healthcare
Q2 2018 Filed on Aug 14, 2018
51,603
$14.63 - $19.19 $755K - $990K
HALO
Halozyme Therapeutics, Inc.

Healthcare
Q2 2018 Filed on Aug 14, 2018
102
$16.87 - $20.3 $1.72K - $2.07K
Pluristem Therapeutics Inc
Q2 2018 Filed on Aug 14, 2018
27,640
N/A
Precipio Inc
Q2 2018 Filed on Aug 14, 2018
764,411
N/A
Alexion Pharmaceuticals Inc
Q2 2018 Filed on Aug 14, 2018
593
N/A
SLDB
Solid Biosciences Inc.

Healthcare
Q2 2018 Filed on Aug 14, 2018
25,000
$7.33 - $43.15 $183K - $1.08M
VNRX
Volitionrx LTD

Healthcare
Q2 2018 Filed on Aug 14, 2018
13,167
$1.88 - $2.41 $24.8K - $31.7K
Eleven Biotherapeutics Inc
Q2 2018 Filed on Aug 14, 2018
1,226,117
N/A
Alnylam Pharmaceuticals Inc
Q2 2018 Filed on Aug 14, 2018
250
N/A
Abbvie Inc
Q2 2018 Filed on Aug 14, 2018
369
N/A
Vical Inc.
Q2 2018 Filed on Aug 14, 2018
59,832
N/A
AKBA
Akebia Therapeutics, Inc.

Healthcare
Q2 2018 Filed on Aug 14, 2018
102,338
$9.15 - $11.34 $936K - $1.16M
Acceleron Pharma Inc
Q2 2018 Filed on Aug 14, 2018
8,646
N/A
Apricus Biosciences Inc
Q2 2018 Filed on Aug 14, 2018
1,800,000
N/A
AXSM
Axsome Therapeutics, Inc.

Healthcare
Q2 2018 Filed on Aug 14, 2018
81,159
$2.15 - $3.6 $174K - $292K
Transenterix Inc
Q2 2018 Filed on Aug 14, 2018
256,715
N/A
Sage Therapeutics Inc
Q1 2018 Filed on May 15, 2018
350
N/A
Agenus Inc
Q1 2018 Filed on May 15, 2018
2,860
N/A
Idera Pharmaceuticals Inc
Q1 2018 Filed on May 15, 2018
307,987
N/A
Regenxbio Inc
Q1 2018 Filed on May 15, 2018
81
N/A
Intercept Pharmaceuticals Inc
Q1 2018 Filed on May 15, 2018
447
N/A
Oncosec Medical Inc
Q1 2018 Filed on May 15, 2018
153,137
N/A
Amag Pharmaceuticals Inc
Q1 2018 Filed on May 15, 2018
553
N/A
Alnylam Pharmaceuticals Inc
Q1 2018 Filed on May 15, 2018
941
N/A
Advaxis Inc
Q1 2018 Filed on May 15, 2018
270
N/A
Heat Biologics Inc
Q1 2018 Filed on May 15, 2018
2,615,123
N/A
Galena Biopharma Inc
Q1 2018 Filed on May 15, 2018
2,623,610
N/A
Achillion Pharmaceuticals Inc
Q1 2018 Filed on May 15, 2018
992
N/A
Fibrocell Science Inc
Q1 2018 Filed on May 15, 2018
1,128,588
N/A
Contrafect Corp.
Q1 2018 Filed on May 15, 2018
34,333
N/A
Arca Biopharma Inc
Q1 2018 Filed on May 15, 2018
100,000
N/A
Jaguar Health Inc
Q1 2018 Filed on May 15, 2018
1,045,741
N/A
Axovant Sciences LTD
Q1 2018 Filed on May 15, 2018
2,146
N/A
Halozyme Therapeutics Inc
Q1 2018 Filed on May 15, 2018
4,950
N/A
Galena Biopharma Inc
Q1 2018 Filed on May 15, 2018
7,602
N/A
Oncobiologics Inc
Q1 2018 Filed on May 15, 2018
89,644
N/A
Oncobiologics Inc
Q1 2018 Filed on May 15, 2018
199,193
N/A
Oasmia Pharmaceutical
Q1 2018 Filed on May 15, 2018
19,000
N/A
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email